Sign Up | Log In | What is SocialPicks?

The Stock Idea & Analysis Community

SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.

Are you a stock guru?

Share picks & earn reputation

Mike Havrilla www.BioRunUp.com

Start Tracking Mike Havrilla - Add to Friends - Send Message

Community Rank: Principal (7000 pts) | Member since 07/15/2008

Picks Performance:

Outperforms

73%

of community

What's this?

All-time Return +1.04% (in over 4 years)	Risk (SD) Moderate 0.00%	Sharpe Ratio -2.09
Followers 87	Winning Picks 786 of 1807	Total Views 2575955

Overview

Stocks

Stats

Community

Widget

Shared Picks | Personal Portfolio | Voted Picks | Commented On

View: Shared Picks (Quick) / (Detailed) | Personal Portfolio

Open | Closed

Symbol	SP Sentiment	Date	Return	Market	v.s. Market	Title	Pts
POT		03/12/10	-67.95%	+0.00%	-67.95%	mikehavRx.com News Bytes: $DCTH, $TRA, $P..	9
SPY		03/10/10	+41.32%	+0.00%	+41.32%	mikehavRx.com Index Updates Service Debut..	9
CLSN	N/A	03/05/10	-62.89%	+0.00%	-62.89%	$CLSN: Griffin Rates Celsion Buy, $10 Pri..	9
PPH	N/A	03/04/10	-28.32%	+0.00%	-28.32%	mikehavRx.com Index Updates Service	9
ZIOP		03/04/10	-41.08%	+0.00%	-41.08%	Bullish on ZIOP ...	1
ACCP		02/05/10	n/a	+0.00%	n/a	Updated Executive Summary for Access Phar..	1
AEZS		01/27/10	+117.24%	+0.00%	+117.24%	Bullish on AEZS ...	0
KERX		01/27/10	+153.82%	+0.00%	+153.82%	Keryx / Aeterna Drug Shows Promise in Lat..	9
DNDN		01/17/10	-85.44%	+0.00%	-85.44%	Healthcare Conference Update: A New Strat..	9
SNY		01/12/10	+31.99%	+0.00%	+31.99%	Unilife Medical (UNIFF.PK) (UNI.AX) Poise..	9
CVA		01/11/10	+2.89%	+0.00%	+2.89%	Waste2Energy (OTC: WTEZE.OB) Announces Co..	9
MNTR	N/A	12/23/09	n/a	+0.00%	n/a	Mentor Capital / QI, Cancer Vaccine Inves..	1
NBS		12/16/09	-66.25%	+0.00%	-66.25%	New Era Begins for NeoStem (AMEX: NBS) Fo..	9
UNIFF	N/A	12/13/09	n/a	+0.00%	n/a	Unilife Medical (ASX: UNI.AX) (UNIFF.PK):..	1
CLDA	N/A	11/26/09	n/a	+0.00%	n/a	BioMed Research Reports: Clinical Data (N..	9
PBIO	N/A	11/24/09	-81.49%	+0.00%	-81.49%	Under the Radar Healthcare Stocks: Protox..	9
PUMD	N/A	11/23/09	n/a	+0.00%	n/a	BioMed News Bytes: Transcept, SciClone, P..	1
SCLN	N/A	11/23/09	+89.19%	+0.00%	+89.19%	BioMed News Bytes: Transcept, SciClone, P..	9
TSPT	N/A	11/23/09	+42.99%	+0.00%	+42.99%	BioMed News Bytes: Transcept, SciClone, P..	9
NVO		11/22/09	+153.59%	+0.00%	+153.59%	Diabetes Care: Global Investing Opportuni..	9

« previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
next »

Open | Closed

Symbol	SP Sentiment	Date	Return	Market	v.s. Market	Title	Pts
FAA	N/A	01/26/09	n/a	+0.00%	n/a	Claymore's Airline ETF (FAA) Takes Flight..	1
DCTH		03/28/10	+30.17%	+0.00%	+30.17%	Near-Term Extreme FDA, Clinical Trial Tra..	9
CXSP	N/A	01/21/09	n/a	+0.00%	n/a	Calendar of 163 FDA Decisions and Clinica..	9
CYTX		03/27/10	+1.53%	+0.00%	+1.53%	Single Digit FDA, Clinical Trial Stocks: ..	9
BBH		06/26/09	+10.67%	+0.00%	+10.67%	Investars YOU: New Site for Index Trackin..	9
XBI		06/26/09	+20.68%	+0.00%	+20.68%	Investars YOU: New Site for Index Trackin..	9
IBB		03/19/10	+0.46%	+0.00%	+0.46%	HavRx Regulatory Catalyst Index up 80% si..	9
FRX		04/06/10	+4.84%	+0.00%	+4.84%	FDA, Clinical Trial News: $FRX $IMGG $RPR..	9
FRX		12/09/08	+32.03%	+0.00%	+32.03%	Trading the Trials: Cytori and Cypress Bi..	9
CLDX	N/A	04/03/10	-2.27%	+0.00%	-2.27%	Immune-Based Treatments for Brain Cancer ..	9
IMUC	N/A	11/09/09	n/a	+0.00%	n/a	ImmunoCellular (OTC: IMUC.OB): Griffin Ma..	1
CLDX	N/A	12/23/09	+39.91%	+0.00%	+39.91%	Mentor Capital / QI, Cancer Vaccine Inves..	10
YMI		10/28/09	+11.21%	+0.00%	+11.21%	YM BioSciences (AMEX: YMI): Griffin Reite..	9
ARQL		11/22/08	+149.47%	+0.00%	+149.47%	Navigating the Minefield of Micro-Cap Bio..	9
LCI	N/A	02/26/09	-15.00%	+0.00%	-15.00%	Big Pharma Goes Generic	9
ABT		11/19/09	-1.26%	+0.00%	-1.26%	Epinex Diagnostics: A New Paradigm for Di..	9
LO		02/26/09	+24.31%	+0.00%	+24.31%	Expert Panel Recommends FDA Regulation of..	9
CEPH		06/30/09	+28.37%	+0.00%	+28.37%	FDA Calendar Updates: POZN, AZN, SNY, CEP..	9
CTIC		03/16/10	+36.63%	+0.00%	+36.63%	Regulatory Catalyst Extreme Trades: $APPA..	9
DCTH		03/12/10	+23.68%	+0.00%	+23.68%	mikehavRx.com News Bytes: $DCTH, $TRA, $P..	9

« previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
next »

Similarity to Me ?

Compare Your Portfolio With Mike Havrilla: Enter stocks you like & track your portfolio:

Symbols, separated by space (e.g. AAPL GOOG MSFT)

More about Mike Havrilla

Investment Style:
Aggressive [?]

Avg exp holding time:
384.53 days

Age: 30's
Location: USA

Website:
www.BioRunUp.com

About Me:

I am a pharmacist, writer, marathon runner, and investor. Check out the Ultimate Guide to Biotech Sto ... more

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.